Use of oxycodone controlled-release immediately after NSAIDs: A new approach to obtain good pain control

European Review for Medical and Pharmacological Sciences

Volumn 14, Issue 2, 2010, Pages 113-121

  Tessaro, Leopoldo ^a   Bandieri, E ^b   Costa, G ^c   Fornasier, G ^d   Iorno, V ^e   Pizza, C ^f   Pastacaldi, G ^g   Micheletto, G ^h  

^a Pain and Palliative Care   (Italy)

^b Carpi e Mirandola Hospital   (Italy)

^c Camposampiero Hospital   (Italy)

^d Unit of Pain Therapy and Palliative Care   (Italy)

^e Institute of Dermatological Sciences   (Italy)

^f Oncology Unit   (Italy)

^g Hospital Misericordia a Dolce Prato   (Italy)

^h Unit of Palliative Care   (Italy)

Author keywords

Analgesia; Cancer pain; Chronic pain; NSAID refractory pain; Oxycodone controlled release (CR)

Indexed keywords

NONSTEROID ANTIINFLAMMATORY AGENT; OXYCODONE;

ADULT; AGED; ANALGESIA; ARTICLE; CANCER PAIN; CHRONIC PAIN; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED RELEASE FORMULATION; CONTROLLED STUDY; DRUG EFFICACY; DRUG RELEASE; DRUG TOLERABILITY; DRUG WITHDRAWAL; DYSPHAGIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; ONCOLOGY; OPEN STUDY; PAIN ASSESSMENT; PATIENT ASSESSMENT; PRIMARY HEALTH CARE; PROSPECTIVE STUDY; QUALITY OF LIFE; RANDOMIZED CONTROLLED TRIAL; RATING SCALE; STATISTICAL SIGNIFICANCE; UNSPECIFIED SIDE EFFECT;

ADULT; AGED; AGED, 80 AND OVER; ANALGESICS, OPIOID; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; DELAYED-ACTION PREPARATIONS; FEMALE; HUMANS; MALE; MIDDLE AGED; OXYCODONE; PAIN; PATIENT SATISFACTION; PROSPECTIVE STUDIES; QUALITY OF LIFE;

EID: 77949630171     PISSN: 11283602     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (36)

1. VAINIO A, AUVINEN A. Prevalence of symptoms among patients with advanced cancer: an international collaborative study. Symptom Prevalence Group. J Pain Symptom Manage 1996;12:3-10.
2. EUROPEAN PAIN IN CANCER SURVEY, EUROPEAN ASSOCIATION OF PALLIATIVE CARE. Half of European cancer patients have moderate to severe pain: one in five patients does not receive treatment. J Pain Palliat Care Pharmacother 2007; 21: 51-53.
3. JOST LM. ESMO Minimum Clinical Recommendations for the management of cancer pain. Ann Oncol 2005;16(Suppl 1): i83-85.
4. WORLD HEALTH ORGANISATION. Cancer pain relief. 2nd Edition. Geneva: World Health Organisation; 1996.
5. JOST L. Management of cancer pain: ESMO clinical recommendations. Ann Oncol 2007; 18(Suppl 2): ii92-94.
6. FERRARESE F, BECCHIMANZI G, BERNARDO M, CONTE MA, GIOIA A, OTTAVIANI D, PALOMBA R, PEDELINI G, RIGOTTI L, SCELZI E. Pain treatment with high-dose, controlled-release oxycodone: an Italian perspective. Ther Clin Risk Manag 2008; 4: 665-672.
7. THE USE OF OPIOIDS FOR THE TREATMENT OF CHRONIC PAIN. A consensus statement from the American Academy of Pain Medicine and the American Pain Society. Clin J Pain 1997; 13: 6-8.
8. AMERICAN GERIATRIC SOCIETY. The management of chronic pain in older persons. AGS Panel on Chronic Pain in Older Persons. Geriatrics 1998; 53(Suppl. 3): S8-S24.
9. TRESCOT AM, HELM S, HANSEN H, BENYAMIN R, GLASER SE, ADLAKA R, PATEL S, MANCHIKANTI L. Opioids in the management of chronic non-cancer pain: an update of American Society of the Interventional Pain Physicians' (ASIPP) Guidelines. Pain Physician 2008; 11(2 Suppl): S5-S62.
10. REID CM, MARTIN RM, STERNE JA, DAVIES AN, HANKS GW. Oxycodone for cancer-related pain: meta-analysis of randomized controlled trials. Arch Intern Med 2006; 166: 837-843.
11. STAAHL C, CHRISTRUP LL, ANDERSEN SD, ARENDT-NIELSEN L, DREWES AM. A comparative study of oxycodone and morphine in a multi-modal, tissue-differentiated experimental pain model. Pain 2006; 123: 28-36.
12. STAAHL C, DIMCEVSKI G, ANDERSEN SD, THORSGAARD N, CHRISTRUP LL, ARENDT-NIELSEN L, DREWES AM. Differential effect of opioids in patients with chronic pancreatitis: an experimental pain study. Scand J Gastroenterol 2007; 42: 383-390.
13. HANNA M, O'BRIEN C, WILSON MC. Prolonged-release oxycodone enhances the effects of existing gabapentin therapy in painful diabetic neuropathy patients. Eur J Pain 2008; 12: 804-813.
14. GATTI A, SABATO AF, OCCHIONI R, COLINI BALDESCHI G, REALE C. Controlled-release oxycodone and pregabalin in the treatment of neuropathic pain: results of a multicenter Italian study. Eur Neurol 2009; 61: 129-137.
15. PARRIS WC, JOHNSON BW JR, CROGHAN MK, MOORE MR, KHOJASTEH A, REDER RF, KAIKO RF, BUCKLEY BJ. The use of controlled-release oxycodone for the treatment of chronic cancer pain: a randomized, double-blind study. J Pain Symptom Manage 1998; 16: 205-211.
16. KOIZUMI W, TOMA H, WATANABE K, KATAYAMA K, KAWAHARA M, MATSUI K, TAKIUCHI H, YOSHINO K, ARAKI N, KODAMA K, KIMURA H, KONO I, HASEGAWA H, HATANAKA K, HIRAGA K, TAKEDA F. Efficacy and tolerability of cancer pain management with controlled-release oxycodone tablets in opioid-naive cancer pain patients, starting with 5 mg tablets. Jpn J Clin Oncol 2004; 34: 608-614.
17. FARRAR JT, YOUNG JP, JR., LAMOREAUX L, WERTH JL, POOLE RM. Clinical importance of changes in chronic pain intensity measured on an 11-point numerical pain rating scale. Pain 2001; 94: 149-158.
18. ROWBOTHAM MC. What is a "clinically meaningful" reduction in pain? Pain 2001; 94: 131-132.
19. BONEZZI C, NAVA A, BARBIERI M, BETTAGLIO R, DEMARTINI L, MIOTTI D, et al. [Validazione della versione italiana del Brief Pain Inventory nei pazienti con dolore cronico]. Minerva Anestesiol. 2002; 68: 607-611.
20. CLEELAND CS, RYAN KM. Pain assessment: global use of the Brief Pain Inventory. Ann Acad Med Singapore 1994; 23: 129-138.
21. MERCADANTE S, PORZIO G, FERRERA P, FULFARO F, AIELLI F, FICORELLA C, VERNA L, TIRELLI W, VILLARI P, ARCURI E. Low morphine doses in opioid-naive cancer patients with pain. J Pain Symptom Manage 2006; 31: 242-247.
22. PAN H, ZHANG Z, ZHANG Y, XU N, LU L, DOU C, GUO Y, WU S, YUE J, WU D, DAI Y. Efficacy and tolerability of oxycodone hydrochloride controlled-release tablets in moderate to severe cancer pain. Clin Drug Investig 2007; 27: 259-267.
23. SILVESTRI B, BANDIERI E, DEL PRETE S, IANNIELLO GP, MICHELETTO G, DAMBROSIO M, SABBATINI G, ENDRIZZI L, MARRA A, AITINI E, CALORIO A, GARETTO F, NASTASI G, PIANTEDOSI F, SIDOTI V, SPANU P. Oxycodone controlled-release as first-choice therapy for moderate-to-severe cancer pain in Italian patients: results of an open-label, multicentre, observational study. Clin Drug Investig 2008; 28: 399-407.
24. YU SY. Postmarketing surveillance study of Oxy-Contin tablets for relieving moderate to severe cancer pain. Oncology 2008; 74(Suppl 1): 46-51.
25. MARINANGELI F, CICCOZZI A, LEONARDIS M, ALOISIO L, MAZZEI A, PALADINI A, PORZIO G, MARCHETTI P, VARRASSI G. Use of strong opioids in advanced cancer pain: a randomized trial. J Pain Symptom Manage 2004; 27: 409-416.
26. MALTONI M, SCARPI E, MODONESI C, PASSARDI A, CALPONA S, TURRIZIANI A, SPERANZA R, TASSINARI D, MAGNANI P, SACCANI D, MONTANARI L, ROUDNAS B, AMADORI D, FABBRI L, NANNI O, RAULLI P, POGGI B, FOCHESSATI F, GIANNUNZIO D, BARBAGALLO ML, MINNOTTI V, BETTI M, GIORDANI S, PIAZZA E, SCAPATICCI R, FERRARIO S. A validation study of the WHO analgesic ladder: a two-step vs three-step strategy. Support Care Cancer 2005; 13: 888-894.
27. RILEY J, ROSS JR, RUTTER D, WELLS AU, GOLLER K, DU BOIS R, WELSH K. No pain relief from morphine? Individual variation in sensitivity to morphine and the need to switch to an alternative opioid in cancer patients. Support Care Cancer 2006; 14: 56-64.
28. D'HONNEUR G, GILTON A, SANDOUK P, SCHERRMANN JM, DUVALDESTIN P. Plasma and cerebrospinal fluid concentrations of morphine and morphine glucuronides after oral morphine. The influence of renal failure. Anesthesiology 1994; 81: 87-93.
29. FARRELL A, RICH A. Analgesic use in patients with renal failure. Eur J Palliat Care 2000; 7: 201-205.
30. HASSELSTROM J, ERIKSSON S, PERSSON A, RANE A, SVENSSON JO, SAWE J. The metabolism and bioavailability of morphine in patients with severe liver cirrhosis. Br J Clin Pharmacol 1990; 29: 289-297.
31. LESAGE P, PORTENOY RK. Trends in Cancer Pain Management. Cancer Control 1999; 6: 136-145.
32. RILEY J, ROSS JR, RUTTER D, SHAH S, GWILLIAM B, WELLS AU, WELSH K. A retrospective study of the association between haematological and biochemical parameters and morphine intolerance in patients with cancer pain. Palliat Med 2004; 18: 19-24.
33. RILEY J, EISENBERG E, MULLER-SCHWEFE G, DREWES AM, ARENDT-NIELSEN L. Oxycodone: a review of its use in the management of pain. Curr Med Res Opin 2008; 24: 175-192.
34. WATSON CP, MOULIN D, WATT-WATSON J, GORDON A, EISENHOFFER J. Controlled-release oxycodone relieves neuropathic pain: a randomized controlled trial in painful diabetic neuropathy. Pain 2003; 105: 71-78.
35. WATSON CP, BABUL N. Efficacy of oxycodone in neuropathic pain: a randomized trial in postherpetic neuralgia. Neurology 1998; 50: 1837-1841.
36. ONG EC. Controlled-release oxycodone in the treatment of neuropathic pain of nonmalignant and malignant causes. Oncology 2008; 74(Suppl 1): 72-75.